Scholars@Duke
Journal cover image

17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth?

Publication ,  Journal Article
Hynes, JS; Schwartz, AR; Abdalla, A; Manuck, TA; Dotters-Katz, SK
Published in: Am J Obstet Gynecol MFM
January 2021
Published version (DOI) Link to item

Duke Scholars

Sarah K. Dotters-Katz
Author Sarah K. Dotters-Katz Obstetrics and Gynecology, Maternal Fetal Medicine

Published In

Am J Obstet Gynecol MFM

DOI

10.1016/j.ajogmf.2020.100278

EISSN

2589-9333

Publication Date

January 2021

Volume

3

Issue

1

Start / End Page

100278

Location

United States

Related Subject Headings

  • Uterus
  • Urogenital Abnormalities
  • Premature Birth
  • Pregnancy
  • Infant, Newborn
  • Humans
  • Female
  • 3215 Reproductive medicine
  • 17-alpha-Hydroxyprogesterone
  • 17 alpha-Hydroxyprogesterone Caproate
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hynes, J. S., Schwartz, A. R., Abdalla, A., Manuck, T. A., & Dotters-Katz, S. K. (2021). 17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth? Am J Obstet Gynecol MFM, 3(1), 100278. https://doi.org/10.1016/j.ajogmf.2020.100278
Hynes, Jenna S., Amanda R. Schwartz, Azza Abdalla, Tracy A. Manuck, and Sarah K. Dotters-Katz. “17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth?” Am J Obstet Gynecol MFM 3, no. 1 (January 2021): 100278. https://doi.org/10.1016/j.ajogmf.2020.100278.
Hynes JS, Schwartz AR, Abdalla A, Manuck TA, Dotters-Katz SK. 17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth? Am J Obstet Gynecol MFM. 2021 Jan;3(1):100278.
Hynes, Jenna S., et al. “17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth?” Am J Obstet Gynecol MFM, vol. 3, no. 1, Jan. 2021, p. 100278. Pubmed, doi:10.1016/j.ajogmf.2020.100278.
Hynes JS, Schwartz AR, Abdalla A, Manuck TA, Dotters-Katz SK. 17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth? Am J Obstet Gynecol MFM. 2021 Jan;3(1):100278.
Journal cover image

Published In

Am J Obstet Gynecol MFM

DOI

10.1016/j.ajogmf.2020.100278

EISSN

2589-9333

Publication Date

January 2021

Volume

3

Issue

1

Start / End Page

100278

Location

United States

Related Subject Headings

  • Uterus
  • Urogenital Abnormalities
  • Premature Birth
  • Pregnancy
  • Infant, Newborn
  • Humans
  • Female
  • 3215 Reproductive medicine
  • 17-alpha-Hydroxyprogesterone
  • 17 alpha-Hydroxyprogesterone Caproate